Cervical cancer: open trials in Chile

• NCT07216703

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  IC La Serena Research (Site 0710), La Serena · Bradfordhill (Site 0702), Santiago · Fundación Arturo López Pérez (Site 0701), Santiago · Pontificia Universidad Catolica de Chile-CICUC (Site 0706), Santiago · CIDO SpA-Oncology (Site 0708), Temuco · ONCOCENTRO APYS-ACEREY (Site 0703), Viña del Mar

  Registry updated 2026-11-06

• NCT06330064

  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Trial Treatment · Phase 1/2 · Daiichi Sankyo

  Biocenter, Concepción · Ic La Serena Research, La Serena · Clinica Redsalud Vitacura, Santiago · Centro Del Cancer UC, Santiago · James Lind Centro De Investigacion Del Cancer, Temuco

  Registry updated 2026-10-26

• NCT07593066

  PRIORITY Study in Cervical Cancer

  Research · Pontificia Universidad Catolica de Chile

  Hospital San Pablo, Coquimbo · Hospital regional de Coyhaique, Coyhaique · San Jorge Medical Center UC-Christus Health Network, Santiago · Santa Lucia Medical Center UC-Christus Health Network, Santiago · San Joaquín Medical Center, UCChristus Health Network, Santiago · Ancora San Francisco Medical Center UC Christus Health Network, Santiago · Cancer Centre UC-Christus Nuestra Sra de la Esperanza, Santiago · Hospital de Talca, Talca

  Registry updated 2026-05-18

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error